BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2014
View Archived Issues
Chinese team divulges novel BTK inhibitors
Read More
AstraZeneca and Max Planck Institute to create CVMD chemistry unit
Read More
Cynapsus Therapeutics receives grant and plans phase II study of sublingual apomorphine
Read More
Otonomy releases phase III data for AuriPro in middle ear effusion
Read More
Peroxynitrite decomposing catalyst has antidiabetic effects
Read More
Researchers present results for BP-C1 in patients with stage IV breast cancer
Read More
Phase III results for trelagliptin, an oral, once-weekly DPP IV inhibitor
Read More
LAPS-CA-Exendin 4 designed for patients with type 2 diabetes
Read More
Novel SYK inhibitors described by Merck & Co.
Read More
Actelion Pharmaceuticals prepares new P2X7 antagonists
Read More
Researchers at Pfizer disclose novel BACE inhibitors
Read More
New MAbs for influenza A virus patented by Belgian researchers
Read More
U.S. researchers design new series of protein kinase inhibitors for cancer
Read More
Researchers present phase I results for LGD-6972
Read More
A1M Pharma pre-eclampsia therapy receives European orphan drug designation
Read More
Celgene reports data from phase III POSTURE study
Read More
La Jolla Pharmaceutical to conduct phase III registration program for LJPC-501
Read More
Salix Pharmaceuticals to merge with Cosmo Technologies
Read More
Akashi Therapeutics presents data on HT-100 in Duchenne muscular dystrophy
Read More
Sunesis Pharmaceuticals receives positive opinion on pediatric investigation plan for vosaroxin
Read More
Vaccine for ricin and anthrax achieves simultaneous protection milestone
Read More
Valeant Pharmaceuticals acquires PreCision Dermatology
Read More
FDA places clinical hold on Revolixys Kit phase III trial
Read More
Nuvilex completes preparations for preclinical studies of encapsulated cells in ascites
Read More
Astellas files NDA for isavuconazole in invasive fungal infections
Read More
AbbVie makes revised conditional non-binding proposal offer to Shire
Read More
Humanetics awarded NCI grant to test BIO-300 for radiation-induced erectile dysfunction
Read More